셉틴-9 은 사람에게서 셉틴9 [5] [6] [7] 유전자에 의해 암호화되는 단백질 이다.
상호 작용 SEPT9은 SEPT2 [8] 및 [8] SEPT7과 상호작용하는 것 으로 나타났다.
기능. ANAK , eIF4E , S100A11 과 함께 SEPT9은 의사동물 돌출, 종양세포 이동 및 침입에 [9] 필수적인 것으로 나타났다.
임상적 의의 SEPT9 프로모터의 v2 영역은 일반 대장 [10] 점막에 비해 대장암 조직에서 메틸화된 것으로 나타났다. 대장암 환자의 혈액에서 매우 민감한 실시간 PCR 검사를 이용하여 메틸화 SEPT9이 검출되었다. 암 샘플의 이러한 대체 메틸화 패턴은 일반 조직 [11] [12] 샘플에 비해 유전자의 비정상적인 활성화 또는 억제를 암시합니다.
메틸화 SEPT9를 검출하기 위한 테스트는 대장암 [13] 검사의 첫 번째 옵션으로 제시되지 않았다. 변기 과이악 검사나 분변 면역 검사와 특이성과 민감성이 유사하며,[13] 이러한 검사를 우선적으로 사용해야 합니다.의사가 적극적으로 대장내시경 검사를 권장하고 환자가 이를 거부한 경우, 이 검사는 검사가 [13] 전혀 없는 환자보다 유리합니다.
「 」를 참조해 주세요.
레퍼런스 ^ a b c ENSG00000184640 GRCh38: 앙상블릴리즈 89: ENSG00000282302, ENSG00000184640 - Ensembl , 2017년 5월 ^ a b c GRCm38: 앙상블 릴리즈 89: ENSMUSG000059248 - 앙상블 , 2017년 5월 ^ "Human PubMed Reference:" . National Center for Biotechnology Information, U.S. National Library of Medicine . ^ "Mouse PubMed Reference:" . National Center for Biotechnology Information, U.S. National Library of Medicine . ^ Osaka M, Rowley JD, Zeleznik-Le NJ (May 1999). "MSF (MLL septin-like fusion), a fusion partner gene of MLL, in a therapy-related acute myeloid leukemia with a t(11;17)(q23;q25)" . Proceedings of the National Academy of Sciences of the United States of America . 96 (11): 6428–6433. Bibcode :1999PNAS...96.6428O . doi :10.1073/pnas.96.11.6428 . PMC 26898 . PMID 10339604 . ^ Taki T, Ohnishi H, Shinohara K, Sako M, Bessho F, Yanagisawa M, Hayashi Y (September 1999). "AF17q25, a putative septin family gene, fuses the MLL gene in acute myeloid leukemia with t(11;17)(q23;q25)". Cancer Research . 59 (17): 4261–4265. PMID 10485469 . ^ "Entrez Gene: SEPT9 septin 9" . ^ a b Surka MC, Tsang CW, Trimble WS (October 2002). "The mammalian septin MSF localizes with microtubules and is required for completion of cytokinesis" . Molecular Biology of the Cell . 13 (10): 3532–3545. doi :10.1091/mbc.E02-01-0042 . PMC 129964 . PMID 12388755 . ^ Shankar J, Messenberg A, Chan J, Underhill TM, Foster LJ, Nabi IR (May 2010). "Pseudopodial actin dynamics control epithelial-mesenchymal transition in metastatic cancer cells" . Cancer Research . 70 (9): 3780–3790. doi :10.1158/0008-5472.CAN-09-4439 . PMID 20388789 . ^ Church TR, Wandell M, Lofton-Day C, Mongin SJ, Burger M, Payne SR, et al. (February 2014). "Prospective evaluation of methylated SEPT9 in plasma for detection of asymptomatic colorectal cancer" . Gut . 63 (2): 317–325. doi :10.1136/gutjnl-2012-304149 . PMC 3913123 . PMID 23408352 . ^ Grützmann R, Molnar B, Pilarsky C, Habermann JK, Schlag PM, Saeger HD, et al. (2008). "Sensitive detection of colorectal cancer in peripheral blood by septin 9 DNA methylation assay" . PLOS ONE . 3 (11): e3759. Bibcode :2008PLoSO...3.3759G . doi :10.1371/journal.pone.0003759 . PMC 2582436 . PMID 19018278 . ^ deVos T, Tetzner R, Model F, Weiss G, Schuster M, Distler J, et al. (July 2009). "Circulating methylated SEPT9 DNA in plasma is a biomarker for colorectal cancer" . Clinical Chemistry . 55 (7): 1337–1346. doi :10.1373/clinchem.2008.115808 . PMID 19406918 . ^ a b c 그 이유는 다음과 같습니다American Society for Clinical Pathology , "Five Things Physicians and Patients Should Question" , Choosing Wisely : an initiative of the ABIM Foundation , American Society for Clinical Pathology, retrieved August 1, 2013 . Thompson AJ, Muir AJ, Sulkowski MS, Ge D, Fellay J, Shianna KV, et al. (July 2010). "Interleukin-28B polymorphism improves viral kinetics and is the strongest pretreatment predictor of sustained virologic response in genotype 1 hepatitis C virus". Gastroenterology . 139 (1): 120–9.e18. doi :10.1053/j.gastro.2010.04.013 . PMID 20399780 . Ahlquist DA, Taylor WR, Mahoney DW, Zou H, Domanico M, Thibodeau SN, et al. (March 2012). "The stool DNA test is more accurate than the plasma septin 9 test in detecting colorectal neoplasia" . Clinical Gastroenterology and Hepatology . 10 (3): 272–7.e1. doi :10.1016/j.cgh.2011.10.008 . PMC 3980432 . PMID 22019796 . 추가 정보 Pellegrino JE, George RA, Biegel J, Farlow MR, Gardner K, Caress J, et al. (December 1997). "Hereditary neuralgic amyotrophy: evidence for genetic homogeneity and mapping to chromosome 17q25". Human Genetics . 101 (3): 277–283. doi :10.1007/s004390050629 . PMID 9439655 . S2CID 20263885 . Nagase T, Ishikawa K, Suyama M, Kikuno R, Hirosawa M, Miyajima N, et al. (February 1999). "Prediction of the coding sequences of unidentified human genes. XIII. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro" . DNA Research . 6 (1): 63–70. doi :10.1093/dnares/6.1.63 . PMID 10231032 . Medina M, Marinescu RC, Overhauser J, Kosik KS (January 2000). "Hemizygosity of delta-catenin (CTNND2) is associated with severe mental retardation in cri-du-chat syndrome". Genomics . 63 (2): 157–164. doi :10.1006/geno.1999.6090 . PMID 10673328 . Kalikin LM, Sims HL, Petty EM (January 2000). "Genomic and expression analyses of alternatively spliced transcripts of the MLL septin-like fusion gene (MSF) that map to a 17q25 region of loss in breast and ovarian tumors". Genomics . 63 (2): 165–172. doi :10.1006/geno.1999.6077 . PMID 10673329 . Russell SE, McIlhatton MA, Burrows JF, Donaghy PG, Chanduloy S, Petty EM, et al. (September 2000). "Isolation and mapping of a human septin gene to a region on chromosome 17q, commonly deleted in sporadic epithelial ovarian tumors". Cancer Research . 60 (17): 4729–4734. PMID 10987277 . McIlhatton MA, Burrows JF, Donaghy PG, Chanduloy S, Johnston PG, Russell SE (September 2001). "Genomic organization, complex splicing pattern and expression of a human septin gene on chromosome 17q25.3" . Oncogene . 20 (41): 5930–5939. doi :10.1038/sj.onc.1204752 . PMID 11593400 . Yamamoto K, Shibata F, Yamaguchi M, Miura O (June 2002). "Fusion of MLL and MSF in adult de novo acute myelomonocytic leukemia (M4) with t(11;17)(q23;q25)". International Journal of Hematology . 75 (5): 503–507. doi :10.1007/BF02982114 . PMID 12095151 . S2CID 28022344 . Surka MC, Tsang CW, Trimble WS (October 2002). "The mammalian septin MSF localizes with microtubules and is required for completion of cytokinesis" . Molecular Biology of the Cell . 13 (10): 3532–3545. doi :10.1091/mbc.E02-01-0042 . PMC 129964 . PMID 12388755 . Nagata K, Kawajiri A, Matsui S, Takagishi M, Shiromizu T, Saitoh N, et al. (May 2003). "Filament formation of MSF-A, a mammalian septin, in human mammary epithelial cells depends on interactions with microtubules" . The Journal of Biological Chemistry . 278 (20): 18538–18543. doi :10.1074/jbc.M205246200 . PMID 12626509 . Beausoleil SA, Jedrychowski M, Schwartz D, Elias JE, Villén J, Li J, et al. (August 2004). "Large-scale characterization of HeLa cell nuclear phosphoproteins" . Proceedings of the National Academy of Sciences of the United States of America . 101 (33): 12130–12135. Bibcode :2004PNAS..10112130B . doi :10.1073/pnas.0404720101 . PMC 514446 . PMID 15302935 . Nagata K, Asano T, Nozawa Y, Inagaki M (December 2004). "Biochemical and cell biological analyses of a mammalian septin complex, Sept7/9b/11" . The Journal of Biological Chemistry . 279 (53): 55895–55904. doi :10.1074/jbc.M406153200 . PMID 15485874 . Scott M, Hyland PL, McGregor G, Hillan KJ, Russell SE, Hall PA (July 2005). "Multimodality expression profiling shows SEPT9 to be overexpressed in a wide range of human tumours" . Oncogene . 24 (29): 4688–4700. doi :10.1038/sj.onc.1208574 . PMID 15782116 . Ito H, Iwamoto I, Morishita R, Nozawa Y, Narumiya S, Asano T, Nagata K (October 2005). "Possible role of Rho/Rhotekin signaling in mammalian septin organization" . Oncogene . 24 (47): 7064–7072. doi :10.1038/sj.onc.1208862 . PMID 16007136 . Scott M, McCluggage WG, Hillan KJ, Hall PA, Russell SE (March 2006). "Altered patterns of transcription of the septin gene, SEPT9, in ovarian tumorigenesis" . International Journal of Cancer . 118 (5): 1325–1329. doi :10.1002/ijc.21486 . PMID 16161048 . S2CID 37031210 . Kuhlenbäumer G, Hannibal MC, Nelis E, Schirmacher A, Verpoorten N, Meuleman J, et al. (October 2005). "Mutations in SEPT9 cause hereditary neuralgic amyotrophy". Nature Genetics . 37 (10): 1044–1046. doi :10.1038/ng1649 . PMID 16186812 . S2CID 1756558 .